Smyth M J, Snook M B
Cellular Cytotoxicity Laboratory, The Austin Research Institute, Studley Road, Heidelberg, Victoria, 3084, Australia.
Cell Immunol. 1999 Aug 25;196(1):51-9. doi: 10.1006/cimm.1999.1536.
The ability of beta2-microglobulin-deficient mice (B6.beta2micro(o)) mice to reject syngeneic and major histocompatability (MHC) class I-deficient tumor grafts was examined with a view to determining residual cytotoxic activities that exist in these mice. In particular, the cytotoxic activities of NK cells and CD8(+) cytotoxic T lymphocytes (CTL) reactive against self-MHC class I were assessed using a variety of gene-targeted mice. The creation of mice doubly deficient for perforin and beta2micro (B6.P(o).beta2micro(o)) enabled the determination that perforin was responsible for the cytotoxic activity of NK cells and CD8(+) CTL reactive against self-MHC class I. Dependence on perforin function was demonstrated for the cytotoxicity of these effectors in vitro and for the ability of these effectors to reject a variety of tumors in vivo.
为了确定β2-微球蛋白缺陷小鼠(B6.beta2micro(o)小鼠)中存在的残余细胞毒性活性,研究了其排斥同基因和主要组织相容性复合体(MHC)I类缺陷肿瘤移植物的能力。特别地,使用多种基因靶向小鼠评估了自然杀伤(NK)细胞和针对自身MHC I类有反应的CD8(+)细胞毒性T淋巴细胞(CTL)的细胞毒性活性。穿孔素和β2微球蛋白双缺陷小鼠(B6.P(o).beta2micro(o))的产生使得能够确定穿孔素负责NK细胞和针对自身MHC I类有反应的CD8(+) CTL的细胞毒性活性。这些效应细胞在体外的细胞毒性以及在体内排斥多种肿瘤的能力均显示出对穿孔素功能的依赖性。